Jones Financial Companies
TEVA icon

Jones Financial Companies’s Teva Pharmaceuticals TEVA Stock Holding History

Jones Financial Companies’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.23M Buy
321,219
+303,535
+1,716% +$9.77M ﹤0.01% 852
2025
Q4 		$552K Buy
17,684
+2,598
+17% +$64K ﹤0.01% 1480
2025
Q3 		$277K Buy
15,086
+4,637
+44% +$81.4K ﹤0.01% 1651
2025
Q2 		$175K Sell
10,449
-1,087
-9% -$17.5K ﹤0.01% 1711
2025
Q1 		$174K Buy
11,536
+2,944
+34% +$52.6K ﹤0.01% 1545
2024
Q4 		$189K Buy
8,592
+5,091
+145% +$92.6K ﹤0.01% 1380
2024
Q3 		$61.1K Buy
3,501
+3,394
+3,172% +$59.4K ﹤0.01% 1572
2024
Q2 		$1.73K Buy
+107
New +$1.65K ﹤0.01% 2190
2023
Q2 		– Sell
-200
Closed -$1.77K – 593
2023
Q1 		$1.77K Buy
+200
New +$1.98K ﹤0.01% 556
2016
Q4 		– Sell
-8,051
Closed -$370K – 232
2016
Q3 		$370K Sell
8,051
-499
-6% -$26K ﹤0.01% 186
2016
Q2 		$429K Sell
8,550
-1,101
-11% -$58.6K ﹤0.01% 182
2016
Q1 		$517K Sell
9,651
-1,832
-16% -$107K ﹤0.01% 169
2015
Q4 		$754K Sell
11,483
-1,769
-13% -$109K ﹤0.01% 164
2015
Q3 		$748K Sell
13,252
-1,564
-11% -$101K ﹤0.01% 166
2015
Q2 		$875K Sell
14,816
-1,845
-11% -$114K 0.01% 156
2015
Q1 		$1.04M Sell
16,661
-909
-5% -$52.9K 0.01% 152
2014
Q4 		$1.01M Buy
17,570
+560
+3% +$31.2K 0.01% 160
2014
Q3 		$915K Sell
17,010
-136
-0.8% -$7.21K 0.01% 163
2014
Q2 		$899K Sell
17,146
-65
-0.4% -$3.32K 0.01% 159
2014
Q1 		$910K Sell
17,211
-8,565
-33% -$396K 0.01% 158
2013
Q4 		$1.03M Sell
25,776
-1,993
-7% -$78.5K 0.01% 156
2013
Q3 		$1.05M Buy
27,769
+994
+4% +$38.8K 0.01% 147
2013
Q2 		$1.05M Buy
+26,775
New +$1.04M 0.01% 141

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jones Financial Companies's TEVA Position: Q1 2026 in Review

Jones Financial Companies increased its Teva Pharmaceuticals (TEVA) stake by 1,716% in Q1 2026, buying an estimated $9.77M and bringing the position to 321,219 shares worth $9.23M. The position accounts for ﹤0.01% of the portfolio, ranked #852.

Jones Financial Companies first reported a position in TEVA in Q2 2013 and has held it in 23 quarters since. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Jones Financial Companies held 321,219 shares of Teva Pharmaceuticals worth $9.23M as of Q1 2026.
  • Jones Financial Companies bought 303,535 Teva Pharmaceuticals shares in Q1 2026, an estimated $9.77M.
  • Teva Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #852 holding.
  • Jones Financial Companies first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.